Action mechanisms of Chinese herbal compound at the molecular level

Letters in Drug Design and Discovery

Volumn 6, Issue 5, 2009, Pages 397-402

  Yan, Lu ^a   Lao, Yong Min ^a   Jiang, Jian Guo ^a  

^a SOUTH CHINA UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Cell; Chinese herbal compound; Gene; Molecular biology; Proteomics; Traditional Chinese medicine

Indexed keywords

ACORI GRAMINEI EXTRACT; ANGELICA ROOT EXTRACT; ANGELICA SINENSIS EXTRACT; ASPONGOPUS CHINENSIS EXTRACT; ASTRAGALUS EXTRACT; ATRACTYLODES EXTRACT; CODONOPSIS EXTRACT; CURCUMA LONGA EXTRACT; GECKO EXTRACT; GINSENOSIDE RB 1; GINSENOSIDE RG 1; HEDYOTIS DIFFUSA EXTRACT; HERBACEOUS AGENT; ICARIIN; LIGUSTICUM CHUANXIONG EXTRACT; OXYMATRINE; PAEONIA EXTRACT; PAEONIA RADIX; PANAX NOTOGINSENG EXTRACT; PANAXADIOL; PANAXADIOLSAPONIN; PHYLLANTHUS NIRURI EXTRACT; PINELLIA EXTRACT; PLANT EXTRACT; POLYGALACEAE EXTRACT; RADIX SALVIAE; REALGAR EXTRACT; REHMANNIA EXTRACT; REHMANNIA GLUTINOSA EXTRACT; SOLANUM NIGRUM EXTRACT; UNCLASSIFIED DRUG;

APOPTOSIS; BIOCHIP; CELL MEMBRANE; CELL PROLIFERATION; CHEMICAL COMPOSITION; CHEMICAL STRUCTURE; CHINESE MEDICINE; CLINICAL PRACTICE; CLINICAL RESEARCH; DETOXIFICATION; DNA SEQUENCE; DRUG ACTIVITY; DRUG DETOXIFICATION; DRUG EFFICACY; DRUG FORMULATION; DRUG MECHANISM; DRUG TARGETING; GENE EXPRESSION REGULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MEDICINAL PLANT; MOLECULAR BIOLOGY; MOLECULAR GENETICS; MOLECULAR MODEL; NONHUMAN; ORGANISM; POLYGALACEAE; POLYMERASE CHAIN REACTION; PRESCRIPTION; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SIGNAL TRANSDUCTION; SUPPRESSION SUBTRACTIVE HYBRIDIZATION; TANDEM MASS SPECTROMETRY; TUMOR CELL;

EID: 67650561622     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570180810906050397     Document Type: Review

References (54)

1. Li, W.F.; Jiang, J.G.; Chen, J. Chinese medicine and its modernization demands. Arch. Med. Res., 2008, 39, 246-251.
2. Wang, X. Thinking and method of the study on material base of compound prescripition. J. Shandong Univ. TCM, 2002, 26, 165-166.
3. Li, W.D.; Cai, B.C. Discussion on the research ideas of Chinese herbal compound. Tradit. Chin. Drug Res. Clin. Pharmacol., 2004, 15, 216-218.
4. Xiong, J.X. Chances and difficulties of internationalization of traditional Chinese medicine. Chin. Pharm., 2007, 16, 1-3.
5. Sucher, N.J. Insights from molecular investigations of traditional Chinese herbal stroke medicines: Implications for neuroprotective epilepsy therapy. Epilepsy Behav., 2006, 8, 350-362.
6. Du, G.H. Overview of effective compounds group formulation in traditional Chinese medical prescription. Chin. Tradit. Patent Med., 2002, 11, 878-880.
7. Liu, J.; Xie, H.D.; Li, H.M.; Yan, X.S.; Ming, A.P.; Peng, Y.Q. Boaiwan's effect on cell cycle and related gene expression of human hepatocelluar carcinoma cell line hepG2. Chin. J. Integr. Tradit. West Med. Liver Dis., 2004, 14, 152-157.
8. Kong, L.Y.; Yang, Z.; Min, Z.D. Thinking on the research of the active ingredients of traditional Chinese medicine modernization. Chin. Tradit. Herbal Drugs, 1998, 29, 354-355.
9. Wang, B.X.; Zhou, Q.L. Understanding and research methods of active components of Chinese medicine. China J. Chin. Mater. Med., 2001, 26, 10-13.
10. Huang, T.K.; Kong, L.Y. TCM innovation research and high and new technology application, Chinese Medical Science and Technology Press: Beijing, 2004.
11. Lu, Y.; Duan, J.A.; Ding, A.W.; Chen, J.W.; Zhu, Q. Ideas and methodology in studying material foundation of curative effects of TCM prescriptions by new technologies. World Sci. Tech. Modern Tradit. Chin. Med., 2005, 7, 19-23.
12. Chen, X.; Zhou, Q.L.; Wang, B.X. The metabolism of ginsenoside Rb1 by intestinal bacteria. Acta Pharm. Sin., 1999, 34, 410-414.
13. Chen, X.; Zhou, Q.L.; Wang, B.X. Study on the absorbed components in serum after oral administration of ginsenoside Rb1 in rats. Acta Pharm. Sin., 1999, 34, 481-483.
14. Wang, Y.; Liu, T.H.; Wang, W.; Wang, B.X. Studies on the metabolism of ginsenoside Rg1 by intestinal bacteria and its absorbed metabolites in rat and human sera. Acta Pharm. Sin., 2000, 35, 284-288.
15. Wang, Y.; Wang, B.X.; Liu, T.H.; Minami, M.; Nagata, T.; Ikejima, T. Metabolism of ginsenoside Rg1 by intestinal bacteria. II. Immunological activity of ginsenoside Rg1 and Rh1. Acta Pharmacol. Sin., 2000, 21, 792-796.
16. Wang, M.J.; Wu, B.; Yuan, S.H.; Zhang, W.; Li, W.H.; Gao, H. Study on the molecular mechanisms of compound medicine. Modern. J. Integr. Tradit. Chin. West. Med., 2003, 12, 449-450.
17. Trau, D.; Lee, T.M.; Lao, A.I.; Lenigk, R.; Hsing, I.M.; Ip, N.Y.; Carles, M.C.; Sucher, N.J. Genotyping on a complementary metal oxide semiconductor silicon polymerase chain reaction chip with integrated DNA microarray. Anal. Chem., 2002, 74, 3168-3173.
18. Chen, L.; Wang, D.; Wu, J.; Yu, B.; Zhu, D. Identification of multiple constituents in the traditional Chinese medicine formula GuiZhiFuLing-Wan by HPLC-DAD-MS/MS. J. Pharmaceut. Biomed. Anal., 2009, 49, 267-275.
19. Kato, M.; Ishige, A.; Anjiki, N.; Yamamoto, M.; Irie, Y.; Taniyama, M.; Kibe, R.; Oka, J.; Benno, Y.; Watanabe, K. Effect of herbal medicine Juzentaihoto on hepatic and intestinal heat shock gene expression requires intestinal microflora in mouse. World J. Gastroenterol., 2007, 13, 2289-2297.
20. Cho, W.C. Proteomics technologies and challenges. Genomics Proteomics Bioinformatics, 2007, 5, 77-85.
21. Song, Y.Y.; Wang, Z.; Qu, X. Effect of some active Chinese herbal fraction on brain tissue proteomic profile of ischemic mouse. Chin. J. Integr. Tradit. West. Med., 2006, 26, 526-528.
22. Lu, X.Q.; Gao, Y. The advances of pharmacology research on the modernization of traditional Chinese medicine compound. Tradit. Chin. Drug Res. Clin. Pharmacol., 2002, 13, 59-61.
23. Ma, Z.C.; Gao, Y.; Tang, H.L.; Wang, S.Q. The effects of Si-Wu- Tang on serum protein of blood deficient mice induced by radiation. China J. Chin. Mater. Med., 2003, 58, 1050-1053.
24. Zhao, L.Y.; Qi, Z.T. Infection of hepatitis C virus and disorder of intracellular signal transduction. Bull. Nat. Sci. Found.Chin., 2002, 1, 23-27.
25. Sun, D.Y.; Guo, Y.L.; Ma, L.G. Cell Signal Transduction; Science Press: Beijing, 2001.
26. Wang, X.S.; Li, J.S. Study of transduction of cell signals and mechanisms of Chinese medicine. World Sci. Tech. Modern. Tradit. Chin. Med., 2003, 5, 46-50.
27. Chen, L.W.; Wang, Y.Q.; Wei, L.C.; Shi, M.; Chan, Y.S. Chinese herbs and herbal extracts for neuroprotection of dopaminergic neurons and potential therapeutic treatment of Parkinson's disease. CNS Neurol. Disord. Drug Targets, 2007, 6, 273-281.
28. Adjei, A.A.; Hidalgo, M. Intracellular signal transduction pathway proteins as targets for cancer therapy. J. Clin. Oncol., 2005, 23, 5386-5403.
29. Wang, J.F.; Dai, S.J.; Niu, J.Z.; Mo, R.G. Experimental study of the inhibiting effects of genistein on the expression of NF-κB in human hepatic cancer cell strain Bel 7402. J. Beijing Univ. TCM, 2001, 24, 16-19.
30. Dai, S.J.; Wang, J.F.; Mo, R.G.; Guo, S.G.; Liu, J.Z. Norcantharid in enhanced the expression of IκBα and inkibited the proliferation of Bel 7402 cells in vitro. Acta Anatom. Sin., 2001, 32, 155-158.
31. Chen, G.G.; Liang, N.C.; Lee, J.F.; Chan, U.P.; Wang, S.H.; Leung, B.C.; Leung, K.L. Over-expression of Bcl-2 against Pteris semipinnata L-induced apoptosis of human colon cancer cells via a NF-kκB-related pathway. Apoptosis, 2004, 9, 619-627.
32. Zhao, A.G.; Zhao, H.L.; Jin, X.J.; Yang, J.K.; Tang, L.D.; Effects of Chinese Jianpi herbs on cell apoptosis and related gene expression in human gastric cancer grafted onto nude mice. World J. Gastroenterol., 2002, 8, 792-796.
33. Zhu, J.Y.; Lavrik, I.N.; Mahlknecht, U.; Giaisi, M.; Proksch, P.; Krammer, P.H.; Li-Weber, M. The traditional Chinese herbal compound rocaglamide preferentially induces apoptosis in leukemia cells by modulation of mitogen-activated protein kinase activies. Int. J. Cancer, 2007, 121, 1839-1846.
34. Tan, K.Y.; Liu, C.B.; Chen, A.H.; Ding, Y.J.; Jin, H.Y.; Seow- Choen, F. The role of traditional Chinese medicine in colorectal cancer treatment. Tech. Coloproctol., 2008, 12, 1-6.
35. Yang, Q.J.; Lei, L.W.; Pan, X.X.; Li, B.; Zhen, C.Y. Study on the apoptosis of stomach adenocarcinoma cells induced by Chinese herbal compound Xianglong pulvis. J. Hubei. Coll. TCM, 1999, 1, 43-45.
36. Sun, H.D.; Jia, L.; Yu, X.X.; Song, Z.L. Study on traditional Chinese medicine recipe in inducing Burkitt's lymphoma cell-Raji cells apoptpsis. J. Leukemia Lymphoma, 2002, 11, 84-86.
37. Cong, Z.; Lin, Z.B. The pharmacological study of Lingzhi (Ganoderma lucidum) and the research of therapeutical principle of "Fuzhengguben" in Traditional Chinese medicine. J. Beijing Med. Coll. 1981, 13, 6-10.
38. Zheng, J.; Liu, Q.; Wang, Z.R.; Li, J.C.; Wang, W.; Ma, A.L.; Ma, J.; Li, J.H.; Xiao, T.B. Blood-activating and stasis-eliminating compound induce K562 cells apoptosis. J. Fourth Mil. Med. Univ., 2003, 24, 427-429.
39. Jin, C.F.; Wang, S.Y.; Cai, Y.W. Research review on the apoptosis of tumor cells induced by Chinese herbal compound. J. Liaoning. Coll. TCM., 2004, 6, 233-234.
40. Molassiotis, A.; Potrata, B.; Cheng, K.K. A systematic review of the effectiveness of Chinese herbal medication in symptom management and improvement of quality of life in adult cancer patients. Complement Ther. Med., 2009, 17, 92-120.
41. Yan, X.J. Interference effects of Chinese drugs on gene expression. Hunan. Guiding. J. TCMP., 2000, 6, 15-17.
42. Zhang, J.M.; Hu, Y.; Wang, H.; Kong, Q.L.; Liu, Q.F.; He, W. Efficacy of CHP II on the brains of PDAPPV717I Transgenic mice. Acta Anat. Sin., 2004, 35, 622-625.
43. Wan, Y.G.; Wan, M.; Fan, Y.; Gu, L.B.; Li M. Effect of the compound of traditional Chinese drugs on gene expression of renal endothelin and its receptor of experimental diabetic nephropathy. China J. Chin. Mater. Med., 2003, 28, 159-162.
44. You, D.J.; Wu, L. The research and development strategy of Chinese pharmaceutical and Chinese new drug; Second Military Medical University Press: Shanghai, 1999.
45. Zhong, D.; Mao, W.; Yang, N.Z.; Zhao, D.X.; Liu, M.P. Effects of Tongmai Oral Solution on the expression of ERK1/2 MAPK signaling pathway. Liaoning J. Tradit. Chin. Med., 2007, 34, 1053-1056.
46. Hou, L.Y.; He, S.Q.; Wen, B.; Lv, Z.P.; Lv, X.Y. Effect and mechanism of Chinese compound medicine on the leptinstimulated proliferation of hepatic stellate cells. J. Clin. Rehabil. Tissue Eng. Res., 2007, 11, 1290-1292.
47. He, D.C.; He, H.; Wu, J.P.; Chen, R.Q. Effect of compound TCM on expression of cyclin D1 gene and adherent molecule in bone marrow radiation lesion mice. Chin. J. Inf. Tradit. Chin. Med., 2004, 11, 980-981.
48. Zhu, D.Z.; Wei, X.; Zhao, L.; Zhou, Y.B.; Li, Q. Effect of sourflavor Chinese herbal formula on cell apoptosis and gene expression in diabetes mellitus type 2 rat model. Tradit. Chin. Drug Res. Clin. Pharmacol., 2006, 17, 21-24.
49. Li, H.Y.; Gu, X.K.; Wang, Q.; Zhang H.C. Studies on the treatment of chronic myelocytic leukemia by the traditional Chinese medicine compound of Qudu Huayu Formula. Pract. J. Cancer, 2007, 22, 237-239.
50. Li, F.; Bai, X.Y.; Chen, X.M.; Cai, G.Y.; Zhang, W.X.; Zhang, X.G. Exploration on effect of Chinese compound recipe on gene expression and regulation of Thl/Th2 cell ratio in kidney of autoimmune MRL/lpr mice by using gene chip. Chin. J. Integr. Tradit. West. Med., 2003, 23, 198-206.
51. Xie, P.; Chen, S.; Liang, Y.Z.; Wang, X.; Tian, R.; Upton, R. Chromatographic fingerprint analysis-a rational approach for quality assessment of traditional Chinese herbal medicine. J. Chromatogr. A, 2006, 1112, 171-180.
52. Frew, S.E.; Sammut, S.M.; Shore, A.F.; Ramjist, J.K.; Al-Bader, S.; Rezaie, R.; Daar, A.S.; Singer, P.A. Chinese health biotech and the billion-patient market. Nat. Biotechnol., 2008, 26, 37-53.
53. Xie, P.S.; Leung, A.Y. Understanding the traditional aspect of Chinese medicine in order to achieve meaningful quality control of Chinese materia medica. J. Chromatogr. A, 2009, 1216, 1933-1940.
54. Yusuke, N. From human genome project to genome medical science: From genome medical science to genome medicine - disease related gene research. Cell Technol., 2005, 24, 1280-1286.